Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C LaRosa

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Coronary Artery Disease|July 1, 1993
Estrogen: risk versus benefit for the prevention of coronary artery diseaseJ C LaRosa
The American Journal of Cardiology|September 28, 1995
Unresolved issues in early trials of cholesterol loweringJ C LaRosa
Coronary Artery Disease|September 1, 1996
The pharmacology and effectiveness of specific lipid-active drugs: estrogen/sex steroidsJ C LaRosa
Clinics in Geriatric Medicine|February 1, 1996
Dyslipidemia and coronary artery disease in the elderlyJ C LaRosa
Annals of Internal Medicine|March 1, 1996
Cholesterol agonisticsJ C LaRosa
International Journal of Fertility|January 1, 1989
Effects of oral contraceptives on circulating lipids and lipoproteins: maximizing benefit, minimizing riskJ C LaRosa
The American Journal of Cardiology|March 20, 1990
At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? United States guidelinesJ C LaRosa
The American Journal of Cardiology|July 27, 2001
Pleiotropic effects of statins and their clinical significanceJ C LaRosa
The American Journal of Medicine|June 6, 1994
Management of postmenopausal women who have hyperlipidemiaJ C Larosa
Circulation|October 1, 1990
The clinical lipid specialist. Task Force on Cholesterol Issues, American Heart AssociationJ C LaRosa
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Coronary Artery Disease|July 1, 1993
Estrogen: risk versus benefit for the prevention of coronary artery diseaseJ C LaRosa
The American Journal of Cardiology|September 28, 1995
Unresolved issues in early trials of cholesterol loweringJ C LaRosa
Coronary Artery Disease|September 1, 1996
The pharmacology and effectiveness of specific lipid-active drugs: estrogen/sex steroidsJ C LaRosa
Clinics in Geriatric Medicine|February 1, 1996
Dyslipidemia and coronary artery disease in the elderlyJ C LaRosa
Annals of Internal Medicine|March 1, 1996
Cholesterol agonisticsJ C LaRosa
International Journal of Fertility|January 1, 1989
Effects of oral contraceptives on circulating lipids and lipoproteins: maximizing benefit, minimizing riskJ C LaRosa
The American Journal of Cardiology|March 20, 1990
At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? United States guidelinesJ C LaRosa
The American Journal of Cardiology|July 27, 2001
Pleiotropic effects of statins and their clinical significanceJ C LaRosa
The American Journal of Medicine|June 6, 1994
Management of postmenopausal women who have hyperlipidemiaJ C Larosa
Circulation|October 1, 1990
The clinical lipid specialist. Task Force on Cholesterol Issues, American Heart AssociationJ C LaRosa
Pageof 9